$242,378
＋3.9%
Chief Development Officer
2024
$190k org
40 hrs/wk
$54k other
--
Chief Development Officer at The Ovarian Cancer Research Fund Inc.
Fiscal year ended December 31, 2024. Published on January 25, 2026.
Total compensation
Jonathan Zeidman has been listed as an employee of The Ovarian Cancer Research Fund Inc. in Form 990 filings since at least fiscal year 2016. Total compensation for Jonathan Zeidman has increased by 54.7% from 2016 to 2024.